Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers

BACKGROUND: As an increasing number of cell and gene therapies are US Food and Drug Administration approved, health care stakeholders are attempting to strike a balance between patient access to innovative treatments and overall affordability. Access decision-makers and employers are evaluating how...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopata, Erin, Terrone, Christopher, Gopalan, Ami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388234/
https://www.ncbi.nlm.nih.gov/pubmed/37133434
http://dx.doi.org/10.18553/jmcp.2023.22436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388234/
https://www.ncbi.nlm.nih.gov/pubmed/37133434
http://dx.doi.org/10.18553/jmcp.2023.22436

Ejemplares similares